Effects of green tea extract administration on the pharmacokinetics of clozapine in rats

Journal of Pharmacy and Pharmacology

Volumn 57, Issue 3, 2005, Pages 311-316

  Jang, E H ^a   Choi, J Y ^a   Park, C S ^a   Lee, S K ^a   Kim, C E ^b   Park, H J ^a   Kang, J S ^c   Lee, J W ^c   Kang, J H ^a  

^a Inha University School of Medicine   (South Korea)

^b Inha University Hospital   (South Korea)

^c Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; CYTOCHROME P450 1A2; GREEN TEA EXTRACT; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG ELIMINATION; DRUG HALF LIFE; ENZYME ACTIVITY; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; WEIGHT GAIN; WEIGHT REDUCTION;

ANIMALS; ANTIPSYCHOTIC AGENTS; AREA UNDER CURVE; CAMELLIA SINENSIS; CLOZAPINE; CYTOCHROME P-450 CYP1A2; HALF-LIFE; HERB-DRUG INTERACTIONS; LIVER; MALE; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; TEA;

EID: 14644415864     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357055687     Document Type: Article

References (28)

1. Allison, D. B., Mentore, J. L., Heo, M., Chandler, L. P., Cappelleri, J. C., Infante, M. C., Weiden, P. J. (1999a) Antipsychotic-induced weight gain: a comprehensive research synthesis. Am. J. Psychiatry 156: 1686-1696
2. Allison, D. B., Fontaine, K. R., Heo, M., Mentore, J. L., Cappelleri, J. C., Chandler, L. P., Weiden, P. J., Cheskin, L. J. (1999b) The distribution of body mass index among individuals with and without schizophrenia. J. Clin. Psychiatry 60: 215-220
3. Baldessarini, R. J., Centorrino, F., Flood, J. G., Volpicelli, S. A., Huston-Lyons, D., Cohen, B. M. (1993) Tissue concentrations of clozapine and its metabolites in the rat. Neuropsychopharmacology 9: 117-124
4. Cai, Y., Anavy, N. D., Chow, H. H. (2002) Contribution of presystemic hepatic extraction to the low oral bioavailability of green tea catechins in rats. Drug Metab. Dispos. 30: 1246-1249
5. Carrillo, J. A., Herraiz, A. G., Ramos, S. B., Benitez, J. (1998) Effects of caffeine withdrawal from the diet on the metabolism of clozapine in schizophrenic patients. J. Clin. Psychopharmacol. 18: 311-316
6. Chantre, P., Lairon, D. (2002) Recent findings of green tea extract AR25 (Exolise) and its activity for the treatment of obesity. Phytomedicine 9: 3-8
7. Chen, L., Bondoc, F. Y., Lee, M. J., Hussin, A. H., Thomas, P. E., Yang, C. S. (1996) Caffeine induces cytochrome P450 1A2: induction of CYP1A2 by tea in rats. Drug Metab. Dispos. 24: 529-533
8. Choc, M. G., Hsuan, F., Honigfeld, G., Robinson, W. T., Ereshefsky, L., Crismon, M. L., Saklad, S. R., Hirschowitz, J., Wagner, R. (1990) Single- vs multiple-dose pharmacokinetics of clozapine in psychiatric patients. Pharm. Res. 7: 347-351
9. Chung, F. L., Schwartz, J., Herzog, C. R., Yang, Y. M. (2003) Tea and cancer prevention: studies in animals and humans. J. Nutr. 133: 3268S-3274S
10. Dain, J. G., Nicoletti, J., Ballard, F. (1997) Biotransformation of clozapine in humans. Drug Metab. Dispos. 25: 603-609
11. Fujiki, H., Suganuma, M., Imai, K., Nakachi, K. (2002) Green tea: cancer preventive beverage and/or drug. Cancer Lett. 188: 9-13
12. Goasduff, T., Dréano, Y., Guillois, B., Ménez, J., Berthou, F. (1996) Induction of liver and kidney CYP1A1/1A2 by caffeine in rat. Biochem. Pharmacol. 52: 1915-1919
13. Hägg, S., Spigset, O., Mjörndal, T., Dahlqvist, R. (2000) Effect of caffeine on clozapine pharmacokinetics in healthy volunteers. Br. J. Clin. Pharmacol. 49: 59-63
14. Henderson, D. C., Cagliero, E., Gray, C., Nasrallah, R. A., Hayden, D. L., Schoenfeld, D. A., Goff, D. C. (2000) Clozapine, diabetes mellitus, weight gain, and lipid abnormalities: a five-year naturalistic study. Am. J. Psychiatry 157: 975-981
15. Kovacs, E. M., Lejeune, M. P., Nijs, I., Westerterp-Plantenga, M. S. (2004) Effects of green tea on weight maintenance after body-weight loss. Br. J. Nutr. 91: 431-437
16. Maliakal, P. P., Wanwimolruk, S. (2001) Effect of herbal teas on hepatic drug metabolizing enzymes in rats. J. Pharm. Pharmacol. 53: 1323-1329
17. Mandel, S., Youdim, M. B. (2004) Catechin polyphenols: neurodegeneration and neuroprotection in neurodegenerative diseases. Free Radic. Biol. Med. 37: 304-317
18. Miller, D. D. (2000) Review and management of clozapine side effects. J. Clin. Psychiatry 61 (Suppl. 8): 14-17
19. Muto, S., Fujita, K., Yamazaki, Y., Kamataki, T. (2001) Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mut. Res. 479: 197-206
20. Nasrallah, H. (2003) A review of the effect of atypical antipsychotics on weight. Psychoneuroendocrinology 28: 83-96
21. Niwattisaiwong, N., Luo, X. X., Coville, P. F., Wanwimolruk, S. (2004) Effects of Chinese, Japanese and Western tea on hepatic P450 enzyme activities in rats. Drug Metabol. Drug Interact. 20: 43-56
22. Ohe, T., Marutani, K., Nakase S. (2001) Catechins are not major components responsible for anti-genotoxic effects of tea extracts against nitroarenes. Mut. Res. 496: 75-81
23. Prior, T. I., Baker, G. B. (2002) Interactions between the cytochrome P450 system and the second-generation antipsychotics. J. Psychiatry Neurosci. 28: 99-112
24. Richelson, E. (1984) Neuroleptic affinities for human brain receptors and their use in predicting adverse effects. J. Clin. Psychiatry 45: 331-336
25. Richelson, E., Souder, T. (2000) Binding of antipsychotic drugs to human brain receptors focus on newer generation compounds. Life Sci. 68: 29-39
26. Riemersma, R. A., Rice-Evans, C. A., Tyrrell, R. M., Clifford, M. N., Lean, M. E. (2001) Tea flavonoids and cardiovascular health. Q J Med 94: 277-282
27. Sueoka, N., Suganuma, M., Sueoka, E., Okabe, S., Matsuyama, S., Imai, K., Nakachi, K., Fujiki, H. (2001) A new function of green tea: prevention of lifestyle-related diseases. Ann. N. Y. Acad. Sci. 928:274-280
28. Sun, L., Lau, C. E. (2000) Intravenous and oral clozapine pharmacokinetics, pharmacodynamics, and concentration-effect relations: acute tolerance. Eur. J. Pharmacol. 398: 225-238